About Daniela
I am responsible for coordinating Platform 3 development as well as product characterization activities by defining the analytical strategy for the assessment during development/characterization phase. This includes selecting the testing strategy within the appropriate quality framework and reporting the test results and conclusions to platform developers and stakeholder.
I am also study director within PMI product testing facility that is Good Laboratory Practice certified for the conduct of preclinical assessment.